semaglutide ckd trial Effects of Once-Weekly on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Safety and Efficacy of Semaglutide

Lancet Diabetes Endocrinol (2020) 8(6):52434

We set realistic expectations from the start, walk through side effects before they happen, and keep the plan moving with follow-up rather than handing you a pen and stepping back

Energy Expenditure Enhancement: The glucagon component of this triple receptor agonist peptide increases resting body rate by 15-25%, providing a unique mechanism not available in GLP-1 or GLP-1/GIP mixes

Studies show that inhibiting nicotinamide Nmethyltransferase (NNMT) enhances metabolic health by reducing adipose tissue accumulation, improving insulin sensitivity, and promoting better energy utilization

Each pack of Wegovy 2.4 mg contains: 1 Pre-filled pen with 4 weekly doses